Robert B Nussenblatt1, Frederick Ferris. 1. Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. DrBob@nei.nih.gov
Abstract
PURPOSE: To review the available information concerning the immune mediation of age-related macular degeneration (AMD) and to speculate on proposed mechanisms and immunotherapy. DESIGN: Interpretative essay. METHODS: Literature review and interpretation. RESULTS: An ever-growing body of evidence is gathering concerning the role of the immune system in AMD. Evidence to date suggests that the underlying mechanism leading to AMD is the decline of the ocular downregulatory immune environment. The subsequent activation of the immune system would lead to T-cell sensitization. When combined with local antiangiogenic therapy, several existing immunotherapies may be used to downregulate the immune response, potentially leading to a more efficient inhibition of choroidal neovascularization. CONCLUSIONS: The loss of the downregulatory immune environment is central to the development of AMD, permitting activation of the immune system. If so, immunotherapy could positively alter the course of the disease.
PURPOSE: To review the available information concerning the immune mediation of age-related macular degeneration (AMD) and to speculate on proposed mechanisms and immunotherapy. DESIGN: Interpretative essay. METHODS: Literature review and interpretation. RESULTS: An ever-growing body of evidence is gathering concerning the role of the immune system in AMD. Evidence to date suggests that the underlying mechanism leading to AMD is the decline of the ocular downregulatory immune environment. The subsequent activation of the immune system would lead to T-cell sensitization. When combined with local antiangiogenic therapy, several existing immunotherapies may be used to downregulate the immune response, potentially leading to a more efficient inhibition of choroidal neovascularization. CONCLUSIONS: The loss of the downregulatory immune environment is central to the development of AMD, permitting activation of the immune system. If so, immunotherapy could positively alter the course of the disease.
Authors: Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh Journal: Science Date: 2005-03-10 Impact factor: 47.728
Authors: Hans E Grossniklaus; Päivi H Miskala; W Richard Green; Susan B Bressler; Barbara S Hawkins; Cynthia Toth; David J Wilson; Neil M Bressler Journal: Arch Ophthalmol Date: 2005-07
Authors: Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin Journal: Am J Hum Genet Date: 2005-07-26 Impact factor: 11.025
Authors: Sepideh Zareparsi; Monika Buraczynska; Kari E H Branham; Sapna Shah; Donna Eng; Mingyao Li; Hemant Pawar; Beverly M Yashar; Sayoko E Moroi; Paul R Lichter; Howard R Petty; Julia E Richards; Gonçalo R Abecasis; Victor M Elner; Anand Swaroop Journal: Hum Mol Genet Date: 2005-04-13 Impact factor: 6.150
Authors: Nishal Patel; Masahara Ohbayashi; Alex K Nugent; Kanchan Ramchand; Masako Toda; Kai-Yin Chau; Catey Bunce; Andrew Webster; Alan C Bird; Santa Jeremy Ono; Victor Chong Journal: Immunology Date: 2005-07 Impact factor: 7.397
Authors: Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets Journal: Proc Natl Acad Sci U S A Date: 2005-05-03 Impact factor: 11.205
Authors: Fei E Wang; Connie Zhang; Arvydas Maminishkis; Lijin Dong; Connie Zhi; Rong Li; Jing Zhao; Vladimir Majerciak; Arti B Gaur; Shan Chen; Sheldon S Miller Journal: FASEB J Date: 2010-01-07 Impact factor: 5.191
Authors: Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller Journal: Invest Ophthalmol Vis Sci Date: 2008-04-30 Impact factor: 4.799
Authors: Matthew Campbell; Anh T H Nguyen; Anna-Sophia Kiang; Lawrence C S Tam; Oliviero L Gobbo; Christian Kerskens; Sorcha Ni Dhubhghaill; Marian M Humphries; G-Jane Farrar; Paul F Kenna; Peter Humphries Journal: Proc Natl Acad Sci U S A Date: 2009-10-12 Impact factor: 11.205
Authors: Anna Enzsöly; Petra Dunkel; Zsuzsa Récsán; Hajnalka Gyorffy; Jeanette Tóth; Gábor Marics; Zoltán Bori; Miklós Tóth; Romána Zelkó; Maria Luisa Di Paolo; Péter Mátyus; János Németh Journal: J Neural Transm (Vienna) Date: 2011-02-18 Impact factor: 3.575
Authors: Chandrasekharam N Nagineni; Vijay K Kommineni; Nader Ganjbaksh; Krishnasai K Nagineni; John J Hooks; Barbara Detrick Journal: Aging Dis Date: 2015-11-17 Impact factor: 6.745